NIH Funds $3.4M Study on Menopause's Role in Women's Alzheimer's Risk
Event summary
- Rosalind Franklin University receives $3.4M NIH grant to study perimenopause's impact on Alzheimer's risk in women.
- Research focuses on hormonal changes, particularly estrogen fluctuations, during perimenopause and their effects on brain circuitry.
- Study will examine the hippocampus, a key region for memory, to understand how hormonal disruptions may accelerate Alzheimer's pathology.
- Women have a 1 in 5 lifetime risk of developing Alzheimer's at age 65, compared to 1 in 10 for men.
- Research aims to identify biological factors contributing to the gender disparity in Alzheimer's prevalence.
The big picture
Women are disproportionately affected by Alzheimer's disease, accounting for nearly two-thirds of cases in the U.S. This NIH-funded research at Rosalind Franklin University aims to uncover how hormonal changes during perimenopause may contribute to this disparity. Understanding these biological factors could lead to targeted interventions and reduce the gender gap in Alzheimer's risk. The study's findings may also influence broader industry efforts in neuroscience and women's health research.
What we're watching
- Research Outcomes
- Whether the study identifies specific hormonal mechanisms that increase Alzheimer's vulnerability in women.
- Clinical Applications
- How findings could inform future treatments or preventive strategies for women's brain health.
- Industry Impact
- The pace at which this research could shift focus in Alzheimer's disease prevention toward hormonal factors.